A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy

BACKGROUND: Lupus nephritis (LN) is a severe consequence of systemic lupus erythematosus (SLE) that affects approximately 40% of patients. Pathogenic immune complexes that are characteristic of LN deposit in the kidney and activate immune mediated pathways including the complement system. Complete r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Rachael D., Bannerman, Fariba, Beresford, Michael W., Oni, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329551/
https://www.ncbi.nlm.nih.gov/pubmed/32605540
http://dx.doi.org/10.1186/s12882-020-01888-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329551/
https://www.ncbi.nlm.nih.gov/pubmed/32605540
http://dx.doi.org/10.1186/s12882-020-01888-5

Ejemplares similares